news BlueBird Bio, Inc.

Bluebird Bio Acquired at a 93.4% Discount to Pre-Grizzly Report Price

In February 2025, BlueBird Bio, Inc. announced it had entered into a definitive merger agreement to be acquired by a consortium led by Carlyle and SK Capital. As reported by financial filings in June 2025, the acquisition was finalized via a tender offer. Shareholders were offered specific terms, which included a cash payment of $5.00 per share or a combination of cash and Contingent Value Rights (CVR). On the last trading day on May 29, 2025, BlueBird’s last reported share price was $4.97.

When Grizzly Research published on the stock , BlueBird Bio, Inc., Former High-Flyer, has Crashed to Earth, BlueBird’s shares traded at $74.80.